Literature DB >> 9611910

When is the 'right' time to initiate an assessment of a health technology?

G Mowatt1, D J Bower, J A Brebner, J A Cairns, A M Grant, L McKee.   

Abstract

There is currently no generally accepted formula for the optimal timing of health technology assessments (HTAs). This paper presents some of the relevant issues and then reviews the existing literature on timing of HTAs. It finds that the literature that specifically addresses these issues is limited. There is a consensus that HTAs should be initiated at an early stage of the development of a new health technology, and repeated during the life cycle of the technology. However, the questions of reliably identifying new technologies at an early stage in their development and of deciding on a detectable critical point for starting evaluation are not resolved. It is proposed that a system of categorization and prioritization of health technologies should be developed to allow decisions to be made as to when a strongly precautionary approach is required and how the limited resources available for HTA could be optimally deployed.

Entities:  

Mesh:

Year:  1998        PMID: 9611910     DOI: 10.1017/s0266462300012320

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  4 in total

1.  Evidence-Based Decision Making 3: Health Technology Assessment.

Authors:  Daria O'Reilly; Richard Audas; Kaitryn Campbell; Meredith Vanstone; James M Bowen; Lisa Schwartz; Nazila Assasi; Ron Goeree
Journal:  Methods Mol Biol       Date:  2021

Review 2.  When and how to update systematic reviews.

Authors:  D Moher; A Tsertsvadze; A C Tricco; M Eccles; J Grimshaw; M Sampson; N Barrowman
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

3.  Automated dose dispensing in Danish primary health care - a technology under construction.

Authors:  Hanne Herborg; Lotte S Haugbølle; Anne Lee
Journal:  Pharm Pract (Granada)       Date:  2008-06-17

4.  Assessment of learning curves in complex surgical interventions: a consecutive case-series study.

Authors:  Olympia Papachristofi; David Jenkins; Linda D Sharples
Journal:  Trials       Date:  2016-06-01       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.